2m 2m 2m 2m 2m 2m 2m
CONCORMED SP ADR (CCM)
NYSE
$4.75+$0.19 (+4.19%)
Price as of Jun 23, 2026 4:26 PM EDT- $15.1MMarket Cap
- -21.92%1-Year Change
- Medical Care FacilitiesIndustry
CONCORMED SP ADR (CCM)
$4.75+$0.19 (+4.19%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 460.5M +19.94% | 384.0M -28.55% | 537.4M +13.84% | 472.1M -2.79% | |
Cost of Revenue | 434.7M -6.14% | 463.1M -24.57% | 614.0M -1.68% | 624.5M +15.11% | |
Gross Profit | 25.8M +132.62% | -79.2M +3.33% | -76.6M -49.74% | -152.4M +167.87% | |
Sales and Marketing Expense | 52.2M +7.32% | 48.6M -13.63% | 56.3M -8.43% | 61.5M +14.54% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 36.1M -0.64% | 36.4M -0.95% | 36.7M +6.41% | 34.5M +14.33% | |
Total Operating Expenses | 213.0M -47.33% | 404.4M +22.51% | 330.1M +6.08% | 311.2M -10.52% | |
Operating Profit | -261.5M -50.86% | -532.2M +14.94% | -463.0M -11.82% | -525.0M +14.56% | |
Interest Income | 7.2M -2.73% | 7.4M -32.06% | 10.8M +8.09% | 10.0M +70.02% | |
Interest Expense | -152.3M -21.16% | -193.2M +16.62% | -165.7M +37.65% | -120.4M +63.11% | |
Interest Income and Expense and Net | -145.2M -21.89% | -185.8M +20.02% | -154.8M +40.33% | -110.3M +62.51% | |
Total Nonoperating Income and Expense | -7.7M -16.87% | -9.3M -14.53% | -10.8M -95.00% | -216.6M +17,611.12% | |
Income before Taxes | -373.4M -44.24% | -669.6M +20.52% | -555.6M -33.85% | -839.9M +58.70% | |
Income Taxes | 6.1M +134.64% | -17.5M -28.76% | -24.6M -65.34% | -70.9M +980.06% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -92.8M -69.89% | -308.2M +3.56% | -297.7M -39.21% | -489.7M +80.40% | |
Net Income from Continuing Operations Applicable to Common | -92.8M -69.89% | -308.2M +3.56% | -297.7M -39.21% | -489.7M +80.40% | |
Basic EPS and Net Income | -0.71 -69.79% | -2.35 +3.52% | -2.27 -39.30% | -3.74 -40.26% | |
Diluted EPS and Net Income | -0.71 -69.79% | -2.35 +3.52% | -2.27 -39.30% | -3.74 -40.26% | |
Basic Weighted Average Shares | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | |
Diluted Weighted Average Shares | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 297.8M +37.72% | 216.2M +271.91% | 58.1M -63.27% | 158.3M +0.57% | |
Short-Term Investments | 1,000 -100.00% | 134.6M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 297.8M -15.12% | 350.8M +503.46% | 58.1M -63.27% | 158.3M +0.57% | |
Total Current Assets | 941.9M -4.27% | 984.0M +59.42% | 617.2M -18.77% | 759.8M +30.00% | |
Accumulated Depreciation | 490.7M +24.45% | 394.3M +2.40% | 385.0M +24.93% | 308.2M +37.06% | |
Property and Plant and Equipment and Net | 3.7B +0.55% | 3.7B +4.44% | 3.5B +8.83% | 3.3B +3.63% | |
Total Long-Term Assets | 5.6B -2.39% | 5.7B +5.62% | 5.4B +3.65% | 5.2B -7.09% | |
Total Assets | 6.5B -2.66% | 6.7B +11.11% | 6.1B +0.82% | 6.0B -3.61% | |
Income Taxes Payable | 82.6M -2.27% | 84.5M -16.39% | 101.1M -10.88% | 113.4M -38.51% | |
Total Short-Term Debt | 981.1M -5.00% | 1.0B -0.91% | 1.0B +103.32% | 512.6M +71.23% | |
Total Current Liabilities | 2.0B -8.04% | 2.1B +8.91% | 2.0B +74.04% | 1.1B +39.37% | |
Total Long-Term Debt | 103.2M +8.09% | 95.5M -95.21% | 2.0B -19.32% | 2.5B +13.44% | |
Total Long-Term Liabilities | 2.7B -8.06% | 3.0B +26.65% | 2.4B -17.87% | 2.9B +6.95% | |
Total Liabilities | 4.7B -8.05% | 5.1B +18.61% | 4.3B +7.96% | 4.0B +14.43% | |
Retained Earnings | -4.5B +2.12% | -4.4B +7.58% | -4.1B +7.90% | -3.8B +14.94% | |
Total Stockholders Equity | -2.1B -7.77% | -2.3B +7.47% | -2.1B +13.84% | -1.9B +36.04% | |
Total Shares Outstanding | 84.5M 0.00% | 84.5M -67.58% | 260.5M 0.00% | 260.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -201.8M -49.26% | -397.7M +43.87% | -276.5M +27.59% | -216.7M -39.69% | |
Capital Expenditures | 56.3M -62.64% | 150.8M +33.42% | 113.0M -49.32% | 223.0M -20.07% | |
Cash from Investing Activities | 54.0M +109.09% | -593.4M +1,144.61% | -47.7M -59.86% | -118.8M -79.01% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 197.2M -82.79% | 1.1B +344.80% | 257.7M -32.74% | 383.1M -40.37% | |
Financials Ratio | |||||
Gross Margin | 5.61% +127.19% | -20.62% +44.63% | -14.26% -55.84% | -32.28% +175.56% | |
Operating Margin | -56.78% -59.03% | -138.60% +60.88% | -86.15% -22.54% | -111.22% +17.85% | |
Return on Assets | -1.40% -71.01% | -4.82% -2.29% | -4.94% -38.32% | -8.00% +70.52% | |
Return on Equity | 4.23% -69.76% | 14.00% -6.24% | 14.94% -50.68% | 30.28% +13.41% | |
Revenue Growth | 19.94% +169.83% | -28.55% -306.37% | 13.84% +595.95% | -2.79% -102.37% | |
Current Ratio | 0.48 +4.08% | 0.46 +46.38% | 0.32 -53.32% | 0.68 -6.73% | |
Cash Ratio | 0.15 +49.85% | 0.10 +241.28% | 0.03 -78.90% | 0.14 -27.81% | |
Debt-to-Equity Ratio | -0.52 +4.22% | -0.49 -65.43% | -1.43 -10.62% | -1.60 -11.48% | |
Debt-to-Assets Ratio | 0.17 -1.25% | 0.17 -66.56% | 0.50 +0.93% | 0.50 +24.94% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow